Clinical Trials Browser

NCT02639026 2025-11-25

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Phase 1 Completed

53 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT04581382 2025-07-10

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

Phase EARLY_PHASE1 Completed

18 enrolled

Dermatologic

Melanoma

NCT02318771 2025-05-15

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Phase 1 Completed

41 enrolled

DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Lung Neoplasms, Melanoma

NCT00405405 2025-05-06

Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

Phase 1 Completed

13 enrolled

DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma, Parotid Neoplasms, Thyroid Neoplasms

NCT01973322 2025-01-09

ABSIDE

Phase 2 Completed

34 enrolled

Dermatologic

Melanoma

NCT00975520 2024-11-27

RTN2

Phase NA Completed

50 enrolled

Dermatologic

Melanoma, Recurrence

NCT00003444 2023-06-22

Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin

Phase 3 Completed

167 enrolled

Dermatologic

Melanoma

NCT04435964 2023-03-24

G-DEFINER

Completed

247 enrolled

BreastDermatologicHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Urogenital Neoplasms

NCT01449279 2020-03-02

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

Phase 2 Completed

22 enrolled 14 charts

Dermatologic

Melanoma

NCT00060333 2017-03-17

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma

Phase 2 Completed

20 enrolled 5 charts

Dermatologic

Melanoma

NCT00096382 2015-10-28

Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 2 Completed

34 enrolled 11 charts

Dermatologic

Melanoma

NCT00287196 2013-06-25

Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

Phase 3 Completed

250 enrolled

Dermatologic

Lymphedema, Melanoma

NCT00006233 2011-11-30

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Phase 2 Completed

Dermatologic

Melanoma